SBX — SynBiotic SE Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €14.35m
- €15.66m
- €3.86m
Annual balance sheet for SynBiotic SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | 5.99 | 3.2 | 0.967 | 0.089 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0.922 | 0.727 | 0.491 | 0.565 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.238 | 7.69 | 10.6 | 8.05 | 6.53 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.023 | 5.86 | 5.42 | 4.89 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.238 | 35 | 60.6 | 40.6 | 34.9 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | — | 9.21 | 4.74 | 5.74 | 8.02 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.003 | 9.54 | 25.6 | 18 | 19.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.236 | 25.5 | 35 | 22.6 | 15.8 |
| Total Liabilities & Shareholders' Equity | 0.238 | 35 | 60.6 | 40.6 | 34.9 |
| Total Common Shares Outstanding |